$OKTA

Okta agreed to acquire identity-security startup Permiso for about $200 million, strengthening its identity threat protection for human, machine and AI-agent identities. Ahead of its earnings report on Aug. 26, the stock trades at 86.15x forward P/E. In Q1 FY2027, revenue rose 11% to $765M and non-GAAP EPS rose to $0.91. Q2 guidance: revenue $790M-$794M, non-GAAP EPS $0.95-$0.97. Oppenheimer raised its price target to $170 and KeyBanc to $175.

Okta (OKTA) shares have risen 93.8% over three months and are near a recent peak. On Aug. 12, Citizens JMP Securities upgraded OKTA to “Market Outperform” with a $170 price target ahead of Aug. 26 fiscal Q2 results. In fiscal Q1 2027, revenue rose 11.2% to $765M and adjusted EPS was $0.91. Valuation remains high.

Dynatrace will acquire Arize for $915m in cash and stock, including about $815m in cash and replacement equity awards, to expand AI observability. IGEL partnered with Menlo Security for zero-trust browser access. MongoDB made Atlas available via an MCP server for tools like Claude Code. Okta said an AI agent feature can cut token costs up to 89%.

Okta says its identity-scoped Model Context Protocol (MCP) tool lists can cut AI agent “tool tax” token overhead by filtering tools before they reach the model. Okta’s internal modelling found some permission scenarios reduced visible tools and tool-schema tokens by over 90%, but it gave no absolute token or dollar figures. The company did not cite a live customer deployment.

Okta Inc. said it will hire Scott Morgan as chief legal officer on Aug. 17. Morgan previously led legal and global affairs at Splunk Inc. and succeeds Larissa Schwartz. The move comes as Okta discusses AI-related identity security and after it paid about $200 million for Permiso Security. Morgan will oversee legal, governance, and regulatory functions.

The article compiles major analyst actions across several stocks. Bank of America reiterated CoreWeave as buy after a quarter with 112% YoY revenue growth and a 5% operating margin. It reiterates Tesla as underweight on delivery declines, upgrades Dell to buy with a $510 PT, and Intel to buy after a ~$20bn equity offering. Other calls include Nvidia buy, SpaceX neutral, and multiple rating changes.

Citizens JMP Securities upgraded Okta to Market Outperform and raised its price target to $170, citing rising enterprise demand for identity controls as AI agents expand. The firm links AI security to authorization, privilege management, and activity monitoring, and expects Okta to broaden into governance and threat detection. For the July quarter, it forecasts $791.7M revenue and 94 cents EPS.

24/7 Wall St. lists Wednesday analyst research calls. Upgrades include Hilton (HLT) to Buy with a $365 target, Intuitive Surgical (ISRG) to Outperform with a $500 target, Merck (MRK) to Outperform with a $143 target, and Okta (OKTA) to Outperform with a $170 target. Downgrades include The Gap (GAP) to Hold, and Novo Nordisk (NVO) to Hold. Initiations cover Genmab (GMAB) and Marriott (MAR).

Okta said its Okta for AI Agents product is not expected to materially change fiscal 2027 guidance unless more of the sales pipeline converts quickly. The firm expects modest upside to fiscal Q2 revenue guidance midpoint of $792 million. A raised price target to $170 from $125 was cited, with the stock around $150.

Oppenheimer said Okta’s fiscal Q2 revenue could exceed guidance as sales execution improves. The firm adjusted Okta’s price target to $170 from $125 and kept an Outperform rating, according to the article.